These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29260454)

  • 21. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease.
    Tillerson JL; Caudle WM; Reverón ME; Miller GW
    Neuroscience; 2003; 119(3):899-911. PubMed ID: 12809709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy.
    Zhu J; Dou S; Jiang Y; Chen J; Wang C; Cheng B
    Brain Res; 2019 Jul; 1715():203-212. PubMed ID: 30914252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
    Schlüter OM; Fornai F; Alessandrí MG; Takamori S; Geppert M; Jahn R; Südhof TC
    Neuroscience; 2003; 118(4):985-1002. PubMed ID: 12732244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Involvement of Progranulin for α-Synuclein Reduction through Autolysosome Formation.
    Fujimori H; Ohba T; Nakamura S; Shimazawa M; Hara H
    Biol Pharm Bull; 2023; 46(8):1032-1040. PubMed ID: 37532554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
    Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
    Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
    Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
    J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice.
    Sung YH; Kim SC; Hong HP; Park CY; Shin MS; Kim CJ; Seo JH; Kim DY; Kim DJ; Cho HJ
    Life Sci; 2012 Dec; 91(25-26):1309-16. PubMed ID: 23069581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson's disease mice.
    Jang Y; Koo JH; Kwon I; Kang EB; Um HS; Soya H; Lee Y; Cho JY
    Brain Res; 2017 Jan; 1655():186-193. PubMed ID: 27816415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective effect of anodal transcranial direct current stimulation on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice through modulating mitochondrial dynamics.
    Lee SB; Youn J; Jang W; Yang HO
    Neurochem Int; 2019 Oct; 129():104491. PubMed ID: 31229553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.
    Sampath C; Kalpana R; Ansah T; Charlton C; Hale A; Channon KM; Srinivasan S; Gangula PR
    Dig Dis Sci; 2019 Dec; 64(12):3502-3517. PubMed ID: 31187328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys.
    Chen M; Wang T; Yue F; Li X; Wang P; Li Y; Chan P; Yu S
    Neuroscience; 2015 Feb; 286():383-92. PubMed ID: 25498223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease.
    Rajagopalan S; Rane A; Chinta SJ; Andersen JK
    J Neurosci; 2016 Jan; 36(4):1086-95. PubMed ID: 26818499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson's Disease.
    Massaquoi MS; Liguore WA; Churchill MJ; Moore C; Melrose HL; Meshul CK
    Neuroscience; 2020 May; 433():53-71. PubMed ID: 32142862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glatiramer Acetate Reverses Motor Dysfunction and the Decrease in Tyrosine Hydroxylase Levels in a Mouse Model of Parkinson's Disease.
    Churchill MJ; Cantu MA; Kasanga EA; Moore C; Salvatore MF; Meshul CK
    Neuroscience; 2019 Aug; 414():8-27. PubMed ID: 31220543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice.
    Rathke-Hartlieb S; Kahle PJ; Neumann M; Ozmen L; Haid S; Okochi M; Haass C; Schulz JB
    J Neurochem; 2001 May; 77(4):1181-4. PubMed ID: 11359883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression.
    Pupyshev AB; Korolenko TA; Akopyan AA; Amstislavskaya TG; Tikhonova MA
    Neurosci Lett; 2018 Apr; 672():140-144. PubMed ID: 29203207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.